Form 4: Xylem Inc. Director Robert Friel Reports Acquisition of Common Stock

Robert Friel, a director of Xylem Inc., reported the acquisition of 1,851 shares of common stock at a price of $126.93 per share on May 13, 2025, according to a Form 4 filing with the SEC.

Summary

• On May 13, 2025, Robert Friel, a director of Xylem Inc., acquired 1,851 shares of common stock at $126.93 per share.
• This acquisition was reported in a Form 4 filing with the SEC.
• Following the transaction, Friel directly owns 36,031 shares of Xylem Inc.
• The acquisition includes an award of restricted stock units (RSUs) under the Xylem 2011 Omnibus Incentive Plan, which will vest before the 2026 Annual Meeting of Shareholders.
• Friel has deferred the settlement of the RSU award until separation from service.
• The reported holdings also include additional shares due to dividend reinvestment.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a company director. The acquisition itself could be seen as a slightly positive signal.

Positives

• The director's acquisition of shares may signal confidence in the company's future performance.

Future Outlook

The vesting of restricted stock units is scheduled for the trading day prior to the 2026 Annual Meeting of Shareholders, with settlement deferred until separation from service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares by a director could positively influence shareholder sentiment.

Key Dates

Keywords

Form 4, Xylem Inc., Robert Friel, Stock Acquisition, Director, Common Stock, Beneficial Ownership, SEC Filing, RSU, Dividend Reinvestment